Summary of clinical and laboratory data of study subjects with and without DCE-MRI plaque measurements in the AIM-HIGH clinical trial

This brief data article summarizes the clinical risk factors and laboratory data of a group of subjects recruited for the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes) and an associated magnetic resonance ima...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Kevin D., Hippe, Daniel S., Chen, Huijun, Neradilek, Moni B., Probstfield, Jeffrey L., Peck, Suzanne, Isquith, Daniel A., Canton, Gador, Yuan, Chun, Polissar, Nayak L., Zhao, Xue-Qiao, Kerwin, William S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773570/
https://www.ncbi.nlm.nih.gov/pubmed/26977429
http://dx.doi.org/10.1016/j.dib.2015.12.030
Descripción
Sumario:This brief data article summarizes the clinical risk factors and laboratory data of a group of subjects recruited for the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes) and an associated magnetic resonance imaging (MRI) substudy. The sample is restricted to those on statin therapy at the time of enrollment and data are presented stratified by whether dynamic contrast enhanced MRI (DCE-MRI) markers of carotid plaque vascularity and inflammation were available or not. The data provided herein are directly related to the article “Longer Duration of Statin Therapy is Associated with Decreased Carotid Plaque Vascularity by Magnetic Resonance Imaging” [2].

Ejemplares similares